ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Presence of Complement Activating Donor Specific Antibodies Is Associated with Poor Renal Allograft Survival: Two Centre Retrospective Study.

A. Babu,1,4,5 O. Shaw,2 L. Howe,2 N. Kessaris,3 A. Dorling,3 N. Mamode,3 R. Vaughan,2 N. Krishnan,5 R. Higgins,5 D. MItchell,1 D. Briggs,4 S. Daga.1,5,6

1Warwick Medical School, University of Warwick, Coventry, United Kingdom
2Clinical Transplantation Laboratories, Guy's Hospital, Viapath, London, United Kingdom
3Nephrology and Transplantation, Guy's Hospital, London, United Kingdom
4Histocompatibility and Immunogenetics, NHS Blood and Transfusion, Birmingham, United Kingdom
5Nephrology and Transplantation, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom
6Nephrology and Transplantation, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Meeting: 2017 American Transplant Congress

Abstract number: A54

Keywords: Alloantibodies, Graft survival, HLA antibodies, Kidney transplantation

Session Information

Session Name: Poster Session A: Clinical Science: Kidney Immunosuppression: Desensitization

Session Type: Poster Session

Date: Saturday, April 29, 2017

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall D1

Introduction: Complement fixing donor specific antibodies (DSA) as detected by presence of C3d at the time of rejection is associated with poor graft outcome;no studies have explored the role pre-transplant; especially in Human leucocyte Antigen- Antibody incompatible transplants (HLA-AIT).Methods: Analysed 117 patient samples either complement dependent cytotoxicity (CDC) or Flow Crossmatch(FC) positive at pre-conditioning who underwent direct transplantation after desensitisation. C3d (Immucor) assay was performed and the results correlated with early antibody mediated rejection (EAMR) (within first 30 days) and death censored allograft survival (DCGF). Results: Of 117 cases, C3d positive DSAs were present in 49 (42%) cases and there was trend towards predication of EAMR, although statistical significance not reached (p 0.70).

Status Early AMR No Rejection
C3d positive (49) 20 29
C3d negative (68) 26 42
46 71

C3d DSA correlated significantly with poor DCGF (p < 0.001) The five-year DCGF was 56 % in C3d positive group compared to 86% in negative group.

Discussion: Presence of pre-transplant C3d DSA strongly predicts renal allograft survival. Allograft survival in C3d negative patients is comparable to non-sensitised living donor transplants. This enables the differentiation of IgG antibodies of varying pathogenicity and the potential role of C3d as additional biomarker in pre-transplant workup. Mutivariate analysis is being performed and will be presented at the meeting.

CITATION INFORMATION: Babu A, Shaw O, Howe L, Kessaris N, Dorling A, Mamode N, Vaughan R, Krishnan N, Higgins R, MItchell D, Briggs D, Daga S. Presence of Complement Activating Donor Specific Antibodies Is Associated with Poor Renal Allograft Survival: Two Centre Retrospective Study. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Babu A, Shaw O, Howe L, Kessaris N, Dorling A, Mamode N, Vaughan R, Krishnan N, Higgins R, MItchell D, Briggs D, Daga S. Presence of Complement Activating Donor Specific Antibodies Is Associated with Poor Renal Allograft Survival: Two Centre Retrospective Study. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/presence-of-complement-activating-donor-specific-antibodies-is-associated-with-poor-renal-allograft-survival-two-centre-retrospective-study/. Accessed June 1, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences